Start free

Aspen Neuroscience, Inc. (ASPE) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 9, 2026.

Filings shown
7
Open-market buys
6
Open-market sells
0
Buys, 10b5-1 box not checked
6 of 6

Counts cover the 7 most recent Form 4 filings Tradune holds for ASPE (filed Nov 2 – Nov 9, 2026). SEC EDGAR Form 4 filings for ASPE last checked Nov 21, 2026, 09:00 UTC; the latest ASPE filing Tradune holds was filed Nov 9, 2026. This is not guaranteed to be the complete record — see ASPE's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 7 filings Tradune holds for ASPE filed Nov 2 – Nov 9, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Arch Venture Fund X, L.P.10% owner 3 0 1,333,333 — +$19,999,995
Arch Venture Partners Xiv, L.P.10% owner 1 0 1,200,000 — +$18,000,000
Orbimed Advisors LLCDirector, 10% owner 1 0 1,000,000 — +$15,000,000
Peter A. ThompsonDirector, 10% owner 1 0 1,000,000 — +$15,000,000

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

100/ 100

Purchase cluster incl. officer
3 distinct buyers5 buy · 0 sell txofficer buying

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

Weekly signal history

ASPE appeared in 2 archived weekly editions as a multi-insider cluster, a top net buyer, or both. These are frozen weekly snapshots, not a complete filing history.

  1. Week of Nov 17, 2026
    3 insiders buying · $52,999,995 net 5 open-market buys · $52,999,995 net
  2. Week of Nov 10, 2026
    4 insiders buying · $67,999,995 net 6 open-market buys · $67,999,995 net

An entry means this company met that edition’s displayed cluster or top-buyer threshold. Missing weeks do not mean no insider transaction occurred. All figures are derived from SEC Form 4 filings; open-market buys minus sales are shown as net only when every transaction value was disclosed.

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at ASPE

Insiders reported 6 open-market purchases of ASPE in the trailing 90 days, across 4 distinct buyers. The most recent purchase was reported by Arch Venture Partners Xiv, L.P. (10% owner) on Nov 2, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Faheem Hasnain Executive Chair · filed Nov 9, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 321,672 — 348,330 +1,207% Nov 5, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

Peter A. Thompson Director, 10% owner · filed Nov 4, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Conversion of derivative 616,984 — 1,456,270 (indirect) +74% Nov 2, 2026
Conversion of derivative 625,743 — 2,082,013 (indirect) +43% Nov 2, 2026
Conversion of derivative 507,119 — 2,589,132 (indirect) +24% Nov 2, 2026
Open-market purchase 10b5-1 box not checked 1,000,000 $15.00 3,589,132 (indirect) +39% Nov 2, 2026
Conversion of derivative Series Seed-2 Convertible Preferred Stock 196,541 — — — Nov 2, 2026
Conversion of derivative Series A-1 Convertible Preferred Stock 642,745 — — — Nov 2, 2026
Conversion of derivative Series A-2 Convertible Preferred Stock 616,984 — — — Nov 2, 2026
Conversion of derivative Series B Convertible Preferred Stock 625,743 — — — Nov 2, 2026
Conversion of derivative Series C Convertible Preferred Stock 507,119 — — — Nov 2, 2026
Conversion of derivative 196,541 — 196,541 (indirect) — Nov 2, 2026
Conversion of derivative 642,745 — 839,286 (indirect) +327% Nov 2, 2026

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Orbimed Advisors LLC Director, 10% owner · filed Nov 4, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Conversion of derivative Series B Convertible Preferred Stock 625,743 — — — Nov 2, 2026
Conversion of derivative Series C Convertible Preferred Stock 507,119 — — — Nov 2, 2026
Conversion of derivative Series A-2 Convertible Preferred Stock 616,984 — — — Nov 2, 2026
Conversion of derivative 196,541 — 196,541 (indirect) — Nov 2, 2026
Conversion of derivative 642,745 — 839,286 (indirect) +327% Nov 2, 2026
Conversion of derivative 616,984 — 1,456,270 (indirect) +74% Nov 2, 2026
Conversion of derivative 625,743 — 2,082,013 (indirect) +43% Nov 2, 2026
Conversion of derivative 507,119 — 2,589,132 (indirect) +24% Nov 2, 2026
Open-market purchase 10b5-1 box not checked 1,000,000 $15.00 3,589,132 (indirect) +39% Nov 2, 2026
Conversion of derivative Series Seed-2 Convertible Preferred Stock 196,541 — — — Nov 2, 2026
Conversion of derivative Series A-1 Convertible Preferred Stock 642,745 — — — Nov 2, 2026
Arch Venture Fund X, L.P. 10% owner · filed Nov 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Conversion of derivative Series A-2 Convertible Preferred Stock 286,304 — — — Nov 2, 2026
Conversion of derivative Series A-2 Convertible Preferred Stock 286,304 — — — Nov 2, 2026
Conversion of derivative Series B Convertible Preferred Stock 295,490 — — — Nov 2, 2026
Conversion of derivative Series B Convertible Preferred Stock 295,490 — — — Nov 2, 2026
Conversion of derivative Series C Convertible Preferred Stock 214,355 — — — Nov 2, 2026
Conversion of derivative Series C Convertible Preferred Stock 259,948 — — — Nov 2, 2026
Open-market purchase 10b5-1 box not checked 66,666 $15.00 66,666 — Nov 2, 2026
Conversion of derivative 187,182 — 253,848 +281% Nov 2, 2026
Conversion of derivative 298,258 — 552,106 +117% Nov 2, 2026
Conversion of derivative 286,304 — 838,410 +52% Nov 2, 2026
Conversion of derivative 295,490 — 1,133,900 +35% Nov 2, 2026
Conversion of derivative 259,948 — 1,393,848 +23% Nov 2, 2026
Open-market purchase 10b5-1 box not checked 66,667 $15.00 66,667 — Nov 2, 2026
Conversion of derivative 298,258 — 364,925 +447% Nov 2, 2026
Conversion of derivative 286,304 — 651,229 +78% Nov 2, 2026
Conversion of derivative 295,490 — 946,719 +45% Nov 2, 2026
Conversion of derivative 214,355 — 1,161,074 +23% Nov 2, 2026
Open-market purchase 10b5-1 box not checked 1,200,000 $15.00 1,200,000 (indirect) — Nov 2, 2026
Conversion of derivative Series Seed Convertible Preferred Stock 187,182 — — — Nov 2, 2026
Conversion of derivative Series A-1 Convertible Preferred Stock 298,258 — — — Nov 2, 2026
Conversion of derivative Series A-1 Convertible Preferred Stock 298,258 — — — Nov 2, 2026
Arch Venture Partners Xiv, L.P. 10% owner · filed Nov 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 1,200,000 $15.00 1,200,000 — Nov 2, 2026
Andrew Spaventa Director · filed Nov 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Conversion of derivative 70,194 — 70,194 (indirect) — Nov 2, 2026
Conversion of derivative 180,221 — 180,221 (indirect) — Nov 2, 2026
Conversion of derivative Series Seed Convertible Preferred Stock 70,194 — — — Nov 2, 2026
Conversion of derivative Series C Convertible Preferred Stock 180,221 — — — Nov 2, 2026
Faheem Hasnain Executive Chair · filed Nov 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Conversion of derivative 14,913 — 14,913 (indirect) — Nov 2, 2026
Conversion of derivative 14,316 — 14,316 (indirect) — Nov 2, 2026
Conversion of derivative 7,120 — 7,120 (indirect) — Nov 2, 2026
Conversion of derivative Series A-1 Convertible Preferred Stock 14,913 — — — Nov 2, 2026
Conversion of derivative Series A-2 Convertible Preferred Stock 14,316 — — — Nov 2, 2026
Conversion of derivative Series C Convertible Preferred Stock 7,120 — — — Nov 2, 2026

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to ASPE's (Nov 9, 2026).

Frequently asked about ASPE insider activity

How many insiders bought ASPE stock in the last 90 days?

4 distinct insiders at Aspen Neuroscience, Inc. reported 6 open-market purchases (Form 4 code P) of ASPE shares in the trailing 90 days, the most recent filed by Arch Venture Partners Xiv, L.P. (10% owner) on Nov 2, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Who filed the most recent Form 4 for ASPE?

The most recent Form 4 on this page was filed by Faheem Hasnain (Executive Chair) on Nov 9, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market ASPE insider purchase shown?

The largest open-market purchase among the filings shown was 1,200,000 ASPE shares at $15.00 (about $18,000,000) by Arch Venture Fund X, L.P. (10% owner) on Nov 2, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

Do the recent ASPE insider purchases have the Form 4 10b5-1 box checked?

No. All 6 ASPE open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Arch Venture Partners Xiv, L.P. (10% owner) on Nov 2, 2026, 1,200,000 shares.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for ASPE — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.